# Ovarian Cancer Risk Dial Citations

*This document contains the peer-reviewed studies and citations that provide the relative risk and prevalence data used to calculate the weights in the Harrison Healthcare Risk Dial for ovarian cancer.*

## Table of Contents
- [Age](#age)
- [Asbestos exposure](#asbestos-exposure)
- [Breastfeeding](#breastfeeding)
- [Family history](#family-history)
- [High parity](#high-parity)
- [Hysterectomy](#hysterectomy)
- [Oral contraceptives](#oral-contraceptives)
- [Race](#race)
- [Tubal ligation](#tubal-ligation)

---

### Age

 - **Relative risk:**
    - Surveillance Research Program, National Cancer Institute. (2024). SEER*Explorer: An interactive website for SEER cancer statistics. Retrieved January 15, 2024, from https://seer.cancer.gov/statistics-network/explorer/. Data source: SEER Incidence Data, November 2024 Submission (1975-2022), SEER 21 registries.

- **Prevalence:**
    - U.S. Census Bureau. (2021). Age and Sex Composition in the United States, Table 1: Population by Age and Sex 2021 [Dataset]. Retrieved from https://www.census.gov/data/tables/2021/demo/age-and-sex/2021-age-sex-composition.html

### Asbestos exposure

 - **Relative risk:**
    - Camargo, M. C., Stayner, L. T., Straif, K., Reina, M., Al-Alem, U., Demers, P. A., & Landrigan, P. J. (2011). Occupational Exposure to Asbestos and Ovarian Cancer: A Meta-analysis. *Environmental Health Perspectives*, 119(9), 1211–1217. [DOI: 10.1289/ehp.1003283](https://doi.org/10.1289/ehp.1003283)
      - JBI Score: 86.4 [See report](../jbi-reports/Camargo%20et%20al.%20(2011).md)

 - **Prevalence:**
    - Li, D.-P., Du, C., Zhang, Z.-M., Li, G.-X., Yu, Z.-F., Wang, X., Li, P.-F., Cheng, C., Liu, Y.-P., & Zhao, Y.-S. (2014). Breastfeeding and Ovarian Cancer Risk: a Systematic Review and Meta-analysis of 40 Epidemiological Studies. Asian Pacific Journal of Cancer Prevention, 15(12), 4829–4837. [DOI: 10.7314/apjcp.2014.15.12.4829](https://doi.org/10.7314/apjcp.2014.15.12.4829)
      - JBI Score: 100 [See report](../jbi-reports/Li%20et%20al.%20(2014).md)

### Breastfeeding

 - **Relative risk:**
    - Li, D., Du, C., Zhang, Z., Li, G., Yu, Z., Wang, X., ... Zhao, Y. (2014) Breastfeeding and Ovarian Cancer Risk: a Systematic Review and Meta-analysis of 40 Epidemiological Studies. *Asian Pacific Journal of Cancer Prevention*, 15(12), 4829-4837. [DOI: 10.7314/apjcp.2014.15.12.4829](https://doi.org/10.7314/apjcp.2014.15.12.4829)
      - JBI Score: 100.0 [See report](../jbi-reports/Li%20et%20al.%20(2014).md)

 - **Prevalence:**
    - Mills, P. K., Riordan, D. G., & Cress, R. D. (2004). Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California. *Gynecologic Oncology*, 95(1), 215–225. [DOI: 10.1016/j.ygyno.2004.07.012](https://doi.org/10.1016/j.ygyno.2004.07.012)
      - JBI Score: 80.0 [See report](../jbi-reports/Mills%20et%20al.%20(2004).md)

### Family history

 - **Relative risk:**
    - Stratton, J. F., Pharoah, P., Smith, S. K., Easton, D., & Ponder, B. A. J. (1998). A systematic review and meta-analysis of family history and risk of ovarian cancer. *BJOG: An International Journal of Obstetrics & Gynaecology*, 105(5), 493–499. [DOI: 10.1111/j.1471-0528.1998.tb10148.x](https://doi.org/10.1111/j.1471-0528.1998.tb10148.x)
      - JBI Score: 86.4 [See report](../jbi-reports/Stratton%20et%20al.%20(1998).md)

 - **Prevalence:**
    - Pinsky, P. F. (2003). Reported Family History of Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. *American Journal of Epidemiology*, 157(9), 792–799. [DOI: 10.1093/aje/kwg043](https://doi.org/10.1093/aje/kwg043)
      - JBI Score: 81.8 [See report](../jbi-reports/Pinsky%20et%20al.%20(2003).md)

### High parity

 - **Relative risk:**
    - Tsilidis, K. K., Allen, N. E., Key, T. J., Dossus, L., Lukanova, A., Bakken, K., Lund, E., Fournier, A., Overvad, K., Hansen, L., Tjønneland, A., Fedirko, V., Rinaldi, S., Romieu, I., Clavel-Chapelon, F., Engel, P., Kaaks, R., Schütze, M., Steffen, A., Riboli, E. (2011). Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition. *British Journal of Cancer*, 105(9), 1436–1442. [DOI: 10.1038/bjc.2011.371](https://doi.org/10.1038/bjc.2011.371)
      - JBI Score: 90.9 [See report](../jbi-reports/Tsilidis%20et%20al.%20(2011).md)

 - **Prevalence:**
    - U.S. Census Bureau. (2023). Fertility historical time series visualizations. [Dataset](https://www2.census.gov/programs-surveys/demo/tables/fertility/time-series/his-cps/h2.xlsx). U.S. Census Bureau. https://www.census.gov/library/visualizations/time-series/demo/his-cps.html

### Hysterectomy

 - **Relative risk:**
    - Rice, M. S., Murphy, M. A., & Tworoger, S. S. (2012). Tubal ligation, hysterectomy and ovarian cancer: A meta-analysis. *Journal of Ovarian Research*, 5(1), 13.[DOI: 10.1186/1757-2215-5-13](https://doi.org/10.1186/1757-2215-5-13)
      - JBI Score: 81.8 [See report](../jbi-reports/Rice%20et%20al.%20(2012).md)

 - **Prevalence:**
    - Gopalani, S. V., Dasari, S. R., Adam, E. E., Thompson, T. D., White, M. C., & Saraiya, M. (2023). Variation in hysterectomy prevalence and trends among U.S. States and Territories—Behavioral Risk Factor Surveillance System, 2012–2020. *Cancer Causes & Control*, 34(10), 829–835. [DOI: 10.1007/s10552-023-01735-6](https://doi.org/10.1007/s10552-023-01735-6)
      - JBI Score: 88.9 [See report](../jbi-reports/Gopalani%20et%20al.%20(2023).md)

### Oral contraceptives

 - **Relative risk and prevalence:**
    - Tsilidis, K. K., Allen, N. E., Key, T. J., Dossus, L., Lukanova, A., Bakken, K., Lund, E., Fournier, A., Overvad, K., Hansen, L., Tjønneland, A., Fedirko, V., Rinaldi, S., Romieu, I., Clavel-Chapelon, F., Engel, P., Kaaks, R., Schütze, M., Steffen, A., Riboli, E. (2011). Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition. *British Journal of Cancer*, 105(9), 1436–1442. [DOI: 10.1038/bjc.2011.371](https://doi.org/10.1038/bjc.2011.371)
      - JBI Score: 90.9 [See report](../jbi-reports/Tsilidis%20et%20al.%20(2011).md)

### Race

 - **Relative risk:**
    - Surveillance Research Program, National Cancer Institute. (2024). SEER*Explorer: An interactive website for SEER cancer statistics. Retrieved January 15, 2024, from https://seer.cancer.gov/statistics-network/explorer/. Data source: SEER Incidence Data, November 2024 Submission (1975-2022), SEER 21 registries.

- **Prevalence:**
    - USAFacts. (2021). Our changing population: United States population between January 1, 2020 and January 1, 2021. Retrieved from https://usafacts.org/data/topics/people-society/population-and-demographics/our-changing-population/?endDate=2021-01-01&startDate=2020-01-01

### Tubal ligation

 - **Relative risk:**
    - Rice, M. S., Murphy, M. A., & Tworoger, S. S. (2012). Tubal ligation, hysterectomy and ovarian cancer: A meta-analysis. *Journal of Ovarian Research*, 5(1), 13.[DOI: 10.1186/1757-2215-5-13](https://doi.org/10.1186/1757-2215-5-13)
      - JBI Score: 81.8 [See report](../jbi-reports/Rice%20et%20al.%20(2012).md)
    
 - **Prevalence:**
    - Daniels, K., & Abma, J. C. (2020, October). Current contraceptive status among women aged 15–49: United States, 2017–2019 (NCHS Data Brief No. 388). National Center for Health Statistics. https://www.cdc.gov/nchs/products/databriefs/db388.htm
